NCT01452113View on ClinicalTrials.gov

Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy

PHASE2CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

January 31, 2013

Study Completion Date

March 31, 2013

Conditions

Diabetes Mellitus

Interventions

DRUG

Vildagliptin

one 50 mg tablet per os

Trial Locations (1)

31059

UH Toulouse, Toulouse

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Institute of Molecular Medicine of Rangueil (I2MR)

UNKNOWN

collaborator

Faculty of Medicine, Toulouse

UNKNOWN

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

University Hospital, Toulouse

OTHER